PF OXYTETRACYCLINE PREMIX 20% WW POWDER
Country: Malaysia
Language: English
Source: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
Summary of Product characteristics
(SPC)
03-02-2018
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
OXYTETRACYCLINE DIHYDRATE
Available from:
Panfast Marketing (m) Sdn Bhd
INN (International Name):
OXYTETRACYCLINE DIHYDRATE
Units in package:
25 kg
Manufactured by:
Shennong Animal Health (Malaysia) Sdn. Bhd.
Summary of Product characteristics
PF OXYTETRACYCLINE PREMIX 20% W/W POWDER
[Type text]
[Type text]
DISTRIBUTED BY:
PANFAST MARKETING (M) SDN.BHD.
PENANG SCIENCE PARK 1102, MUKIM 13, LORONG PERINDUSTRIAN BUKIT
MINYAK 18, KAWASAN PERINDUSTRIAN BUKIT MINYAK,
14100 SIMPANG AMPAT, PENANG, MALAYSIA
TEL: +604-5016868 FAX: +604-5016866
MANUFACTURED BY:
SHENNONG ANIMAL HEALTH (M) SDN.BHD.
No.6, 8, 10, Jalan Industri USJ 1/19, Taman Perindustrian USJ 1
47610 SUBANG JAYA, Selangor Darul Ehsan, Malaysia.
Tel: 03-8011 4646
Fax : 03-8024 1166
COMPOSITION:
Oxytetracycline (as Oxytetracycline Dihydrate).....200mg
Exp.
Qs……………………………….………………..………………….…1g
DESCRIPTION
White colour powder
PHARMACODYNAMIC
Oxytetracycline
(OTC)
is
a
broad-spectrum
antibiotic.
Its
mode of action is bacteriostatic by inhibition of prokaryotic
protein synthesis at the ribosomal level. It is active against
Gram-positive
and
Gram-negative
aerobic
and
anaerobic
microorganisms, _Mycoplasma_ spp., _Chlamydia_ spp., _Leptospir_
_a_ spp.
and
Rickettsias.
It
has
little
activity
against _Salmonella_ spp., _Escherichia _
_coli_,
Enterobacter
and _Klebsiella_ spp.
and
has
essentially
no
activity
against _Pseudomonas_ spp., _Proteus_ spp. and yeasts.
PHARMACOKINETIC
Due to the amphoteric nature of OTC, oral bioavailability is
low (<10%). OTC has excellent distribution properties with a
Volume
of
Distribution
(Vd)
exceeding
1.2
L/kg.
The
compound tends to concentrate in the lung, liver and kidney.
OTC undergoes enterohepatic circulation. It does not appear
to be metabolised to any significant degree. The compound
is mainly excreted as the parent molecule primarily in the
urine but also in the faeces.
INDICATION
For use as an aid in the control of respiratory diseases caused
by bacteria sensitive to oxytetracycline.
ROUTE OF ADMINISTRATION
Oral
RECOMMENDED DOSE
20 mg/kg bodyweight per day in feed for 15 days.
The following inclusion rates may be used as a guide to
obtaining this dose in normal and inappetant pigs.
Food intake expressed as a
percentage
Read the complete document
